| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $358.7M | +15.5% |
| R&D Expense | $13.7M | -59.7% |
| SG&A Expense | $115.7M | +17.8% |
| Interest Expense | $22.2M | +15.9% |
| Pre-tax Income | $37.4M | -80.7% |
| Income Tax | $14.0M | -2.6% |
| Net Income | $23.4M | -87.0% |
| EPS (Basic) | $0.37 | -86.5% |
| EPS (Diluted) | $0.36 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $305.0M | +57.6% |
| Inventory | $33.7M | -17.2% |
| Current Assets | $554.3M | +61.0% |
| Total Assets | $1.30B | +4.6% |
| Current Liabilities | $236.1M | +519.1% |
| Long-term Debt | $256.3M | -42.6% |
| Stockholders' Equity | $691.2M | +2.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $188.7M | +33.8% |
| Capital Expenditures | $270K | -34.3% |
| Investing Cash Flow | -$63.8M | +4.5% |
| Financing Cash Flow | -$13.5M | +92.2% |
| Free Cash Flow | $188.4M | +34.0% |
| -83.6% |